Risk Management in Accordance with EN ISO 14971:2012

All industry professionals, regardless of functional roles, will benefit from this training, especially if you are involved in the day-to-day activities associated with your organization’s product development or manufacturing operations. The application of risk management is a salient requirement needed for introducing medical devices that are safe and effective in their intended use.

For organizations that introduce finished medical device into the EU, EN ISO 14971:2012 is considered a Harmonized Standard. Although the use of Harmonized Standards is strongly recommended in the EU, it is nearly an impossible task to gain product application approvals without evidence of compliance with EN ISO 14971:2012. In the United States, the FDA recognizes ISO 14971:2007 as a Consensus Standard.

The application of risk management, although clearly focused on product development, is really applicable throughout the entire product lifecycle. There are many nuances associated with the effective application of 14971; however, there are three salient elements associated with risk management that need to be clearly understood: (a) the Risk Management Plan; (b) the Risk Management File; and (c) the Risk Management Report. When properly employed during product development, risk management tools are vital in support of the design and development of finished medical devices that are safe and effective in their intended use.

Areas Covered in the Session :

• General requirements for risk management
• The risk management process
• Management responsibilities
• Qualifications of Personnel
• The Risk Management Plan (RMP) and the Risk Management File (RMF)
• Elements of risk analysis
• The evaluation of risk
• Elements of risk control
• Evaluation of residual risk
• Risk Management Report (RMR)
• Production and post-product information

Who Should Attend:

• Quality Departments
• Regulatory Departments
• Design Engineers
• Manufacturing Engineers
• Project Managers

Course Director: DR. CHRISTOPHER J. DEVINE ‎

Dr. Christopher Joseph Devine is the president and founder of Devine Guidance International, Inc., (DGII) a consulting firm providing regulatory and quality compliance support for the medical device industry. Prior to launching DGII, Dr. D spent 14-years with Boston Scientific Corporation working in a variety of quality and regulatory management roles. Additionally, Dr. Devine is the author of Devine Guidance, a weekly blog focusing on quality and regulatory compliance issues facing the medical device industry; and published by the Medical Device Summit, an e-magazine. Furthermore, Dr. Devine has 35-years of combined experience in the fields of quality assurance and regulatory affairs; and is a senior member of the American Society of Quality (ASQ), a member of Regulatory Affairs Professionals Society (RAPS), a member of the Society of Manufacturing Engineers (SME), and a member of the Project Management Institute (PMI). Dr. Devine received his doctorate from Northcentral University, with his doctoral dissertation entitled, “Exploring the Effectiveness of Defensive-Receiving Inspection for Medical Device Manufacturers: A Mixed-Method Study. Finally, Dr. Devine is the author of five books on quality and regulatory compliance.